Florida International University and Phase Holographic Imaging collaborate to fight cancer

Florida International University (FIU) and Phase Holographic Imaging (PHI) have entered a collaboration agreement. To determine the scope of a long-term collaboration, PHI will initially provide FIU with a HoloMonitor instrument during 4 months. The instrument will be used to characterize breast cancer stem cells.

Additional information about the collaboration has been published on the university’s website, http://breakthroughs.fiu.edu/2015/08/13/fight-against-cancer-fueled-by-public-private-collaborations.

For additional information, please contact:

Peter Egelberg, CEO

Tel: +46 703 19 42 74

E-mail: peter.egelberg@phiab.se

Web: www.phiab.se

Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.